BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33757531)

  • 1. Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China.
    Wang W; Zhang T; Zheng W; Zhong L; Wang L; Li J; Liu Q; Dong Y; Song H
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):44. PubMed ID: 33757531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
    Meyts I; Aksentijevich I
    J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
    Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
    J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance.
    Schnappauf O; Zhou Q; Moura NS; Ombrello AK; Michael DG; Deuitch N; Barron K; Stone DL; Hoffmann P; Hershfield M; Applegate C; Bjornsson HT; Beck DB; Witmer PD; Sobreira N; Wohler E; Chiorini JA; Center TAG; Dalgard CL; Center NIS; Kastner DL; Aksentijevich I
    J Clin Immunol; 2020 Aug; 40(6):917-926. PubMed ID: 32638197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cohort Study on Deficiency of ADA2 from China.
    Li GM; Han X; Wu Y; Wang W; Tang HX; Lu MP; Tang XM; Lin Y; Deng F; Yang J; Wang XN; Liu CC; Zheng WJ; Wu BB; Zhou F; Luo H; Zhang L; Liu HM; Guan WZ; Wang SH; Tao PF; Jin TJ; Fang R; Wu Y; Zhang J; Zhang Y; Zhang TN; Yin W; Guo L; Tang WJ; Chang H; Zhang QY; Li XZ; Li JG; Zhou ZX; Yang SR; Yang KK; Xu H; Song HM; Deuitch NT; Lee PY; Zhou Q; Sun L
    J Clin Immunol; 2023 May; 43(4):835-845. PubMed ID: 36807221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation.
    Nihira H; Izawa K; Ito M; Umebayashi H; Okano T; Kajikawa S; Nanishi E; Keino D; Murakami K; Isa-Nishitani M; Shiba T; Honda Y; Hijikata A; Yasu T; Kubota T; Hasegawa Y; Kawashima Y; Nakano N; Takada H; Ohga S; Heike T; Takita J; Ohara O; Takei S; Takahashi M; Kanegane H; Morio T; Iwaki-Egawa S; Sasahara Y; Nishikomori R; Yasumi T
    J Allergy Clin Immunol; 2021 Aug; 148(2):550-562. PubMed ID: 33529688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience.
    Rama M; Duflos C; Melki I; Bessis D; Bonhomme A; Martin H; Doummar D; Valence S; Rodriguez D; Carme E; Genevieve D; Heimdal K; Insalaco A; Franck N; Queyrel-Moranne V; Tieulie N; London J; Uettwiller F; Georgin-Lavialle S; Belot A; Koné-Paut I; Hentgen V; Boursier G; Touitou I; Sarrabay G
    Eur J Hum Genet; 2018 Jul; 26(7):960-971. PubMed ID: 29681619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult-onset deficiency of adenosine deaminase 2-a case report and literature review.
    Zhang B; Sun Y; Xu N; Wang W; Huang X; Chen J; Shen M; Wang R; Zeng X; Zhang X
    Clin Rheumatol; 2021 Oct; 40(10):4325-4339. PubMed ID: 33638065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
    Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
    Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.
    Yap JY; Moens L; Lin MW; Kane A; Kelleher A; Toong C; Wu KHC; Sewell WA; Phan TG; Hollway GE; Enthoven K; Gray PE; Casas-Martin J; Wouters C; De Somer L; Hershfield M; Bucciol G; Delafontaine S; Ma CS; Tangye SG; Meyts I
    J Clin Immunol; 2021 Nov; 41(8):1915-1935. PubMed ID: 34657246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2.
    Carmona-Rivera C; Khaznadar SS; Shwin KW; Irizarry-Caro JA; O'Neil LJ; Liu Y; Jacobson KA; Ombrello AK; Stone DL; Tsai WL; Kastner DL; Aksentijevich I; Kaplan MJ; Grayson PC
    Blood; 2019 Jul; 134(4):395-406. PubMed ID: 31015188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme activity in dried blood spot as a diagnostic tool for adenosine deaminase 2 deficiency.
    Ito M; Nihira H; Izawa K; Yasumi T; Nishikomori R; Iwaki-Egawa S
    Anal Biochem; 2021 Sep; 628():114292. PubMed ID: 34171384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.
    Sahin S; Adrovic A; Barut K; Ugurlu S; Turanli ET; Ozdogan H; Kasapcopur O
    Rheumatol Int; 2018 Jan; 38(1):129-136. PubMed ID: 28516235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2).
    Clarke K; Campbell C; Omoyinmi E; Hong Y; Al Obaidi M; Sebire N; Brogan PA
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):39. PubMed ID: 31291964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.
    Caorsi R; Penco F; Grossi A; Insalaco A; Omenetti A; Alessio M; Conti G; Marchetti F; Picco P; Tommasini A; Martino S; Malattia C; Gallizzi R; Podda RA; Salis A; Falcini F; Schena F; Garbarino F; Morreale A; Pardeo M; Ventrici C; Passarelli C; Zhou Q; Severino M; Gandolfo C; Damonte G; Martini A; Ravelli A; Aksentijevich I; Ceccherini I; Gattorno M
    Ann Rheum Dis; 2017 Oct; 76(10):1648-1656. PubMed ID: 28522451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.
    Nanthapisal S; Murphy C; Omoyinmi E; Hong Y; Standing A; Berg S; Ekelund M; Jolles S; Harper L; Youngstein T; Gilmour K; Klein NJ; Eleftheriou D; Brogan PA
    Arthritis Rheumatol; 2016 Sep; 68(9):2314-22. PubMed ID: 27059682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monogenic polyarteritis: the lesson of ADA2 deficiency.
    Caorsi R; Penco F; Schena F; Gattorno M
    Pediatr Rheumatol Online J; 2016 Sep; 14(1):51. PubMed ID: 27609179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
    Hashem H; Bucciol G; Ozen S; Unal S; Bozkaya IO; Akarsu N; Taskinen M; Koskenvuo M; Saarela J; Dimitrova D; Hickstein DD; Hsu AP; Holland SM; Krance R; Sasa G; Kumar AR; Müller I; de Sousa MA; Delafontaine S; Moens L; Babor F; Barzaghi F; Cicalese MP; Bredius R; van Montfrans J; Baretta V; Cesaro S; Stepensky P; Benedicte N; Moshous D; Le Guenno G; Boutboul D; Dalal J; Brooks JP; Dokmeci E; Dara J; Lucas CL; Hambleton S; Wilson K; Jolles S; Koc Y; Güngör T; Schnider C; Candotti F; Steinmann S; Schulz A; Chambers C; Hershfield M; Ombrello A; Kanakry JA; Meyts I
    J Clin Immunol; 2021 Oct; 41(7):1633-1647. PubMed ID: 34324127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α.
    Sahin S; Adrovic A; Barut K; Baran S; Tahir Turanli E; Canpolat N; Kizilkilic O; Ozkaya O; Kasapcopur O
    Paediatr Int Child Health; 2020 Feb; 40(1):65-68. PubMed ID: 30642227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.